Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics

E-ISSN： 1875-533x|18|11|1658-1671

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.11, 2011-04, pp. : 1658-1671

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Progress in the Development of Histone Deacetylase Inhibitors as Anti-Cancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 1999-2013

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: From Chromatin Remodeling to Experimental Cancer Therapeutics

Current Medicinal Chemistry, Vol. 10, Iss. 22, 2003-11 ,pp. : 2343-2350

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors: discovery and development as anticancer agents

By Marks Paul A Dokmanovic Milos

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1497-1511

Informa Healthcare

Access to resources Recommend Favorite

Histone deacetylase inhibitors: novel anticancer agents

By Saunders N.A. Popa C. Serewko M.M. Jones S.J. Dicker A.J. Dahler A.L.

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1611-1621

Informa Healthcare

Access to resources Recommend Favorite

Selective Histone Deacetylase Inhibitors with Anticancer Activity

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 4, 2016-02 ,pp. : 415-12

Bentham Science Publishers

Access to resources Recommend Favorite